RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 67-77
  • Magnetic stimulation gains in depression treatment

     Magnetic stimulation gains in depression treatment
    A machine that sends magnetic pulses into a patient's brain has become the new frontier of depression treatment, promising to ease symptoms for those who have found little relief from medication or talk therapy. The treatment, known as transcranial...
  • AbbVie reconsiders its option with Shire

     AbbVie reconsiders its option with Shire
    AbbVie's surprise announcement late Tuesday that it is having second thoughts about its proposed acquisition of Shire raises numerous questions about the future of the deal. The North Chicago-based drugmaker said its board of directors will take...
  • As Rx deaths dip, heroin overdoses surge

    As Rx deaths dip, heroin overdoses surge
    Prescription drug deaths declined in 2012 for the first time in more than a decade, but a surge in fatal heroin overdoses wiped out the modest improvement, according to U.S. government statistics released Wednesday. Fatal heroin overdoses rose 35% to 5,...
  • How to judge Medicare plans

    How to judge Medicare plans
    While much of the nation is preoccupied with Obamacare and picking new health insurance at work, older Americans have deadlines of their own coming up — involving Medicare. We're just a few days away from the two-month period when the nation's...
  • Ebola drug maker Chimerix's stock tumbles after Dallas patient dies

    Shares of Chimerix Inc., the maker of an experimental drug to combat Ebola, sank Wednesday after the death in Dallas of a patient with the disease who received the medicine. About two hours after officials announced the death of Thomas Eric Duncan,...
  • Horizon Pharma defies lawmakers, moves to Ireland

    Horizon Pharma defies lawmakers, moves to Ireland
    Despite growing criticism from lawmakers in Washington, a Deerfield drugmaker on Friday officially planted its corporate flag in Ireland, a move designed in part to lower its tax bill. Horizon Pharma completed its $587 million acquisition of the Irish...
  • Robert B. Reich: Why we allow Big Pharma to rip us off

    According to a new federal database put online last week, pharmaceutical companies and device makers paid doctors some $380 million in speaking and consulting fees over a five-month period in 2013. Some doctors received over $500,000 each, and some got...
  • Texas Ebola patient still critical, now receiving experimental drug

    A Liberian man being treated for Ebola in a Dallas hospital is still in critical condition, but is now receiving an experimental treatment. Thomas Eric Duncan has been in isolation at Texas Health Presbyterian Hospital since Sept. 28, after he came down...
  • New database details payments from medical companies to local doctors

    New database details payments from medical companies to local doctors
    — During the last five months of 2013, Lehigh Valley medical-device manufacturers spent more than $2 million on food, travel, speaking fees and other payments to doctors and hospitals that the companies want to see using and promoting their...
  • AbbVie shares drop as tax rules cloud Shire deal

    AbbVie shares drop as tax rules cloud Shire deal
    Shares in North Chicago-based AbbVie and other drugmakers fell Tuesday after the Obama administration this week issued a string of new rules to crack down on U.S. companies that seek to cut their tax bills by moving their addresses abroad. AbbVie shares...
  • U.S. doctor was treated with experimental Ebola drug TKM-Ebola

    U.S. doctor was treated with experimental Ebola drug TKM-Ebola
    An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week. Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firmĀ ...